205 related articles for article (PubMed ID: 28331112)
21. Impact of epicardial adipose tissue volume quantified by non-contrast electrocardiogram-gated computed tomography on ergonovine-induced epicardial coronary artery spasm.
Ito T; Fujita H; Ichihashi T; Ohte N
Int J Cardiol; 2016 Oct; 221():877-80. PubMed ID: 27434364
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of adjunctive intracoronary administration of acetylcholine following intravenous infusion of ergonovine to provoke coronary artery spasm.
Goto A; Ito S; Kondo H; Nomura Y; Yasue N; Suzumura H; Takeda Y; Tomimoto S; Yamada Y; Horio T; Suzuki S; Fukutomi T; Itoh M
J Cardiol; 1999 Dec; 34(6):309-16. PubMed ID: 10642927
[TBL] [Abstract][Full Text] [Related]
23. Disparity between serotonin- and acetylcholine-provoked coronary artery spasm.
Kanazawa K; Suematsu M; Ishida T; Hirata K; Kawashima S; Akita H; Yokoyama M
Clin Cardiol; 1997 Feb; 20(2):146-52. PubMed ID: 9034644
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of spasm-induced vessels in patients with vasospastic angina and a history of syncope].
Sueda S; Mineoi K; Kondo T; Yano K; Ochi T; Ochi N; Kawada H; Uraoka T
J Cardiol; 1998 Jun; 31(6):331-5. PubMed ID: 9666386
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of right coronary artery first ergonovine provocation test.
Ham HS; Kim KH; Park J; Song YJ; Kim S; Kim DK; Seol SH; Kim DI
Acta Cardiol; 2021 Feb; 76(1):38-45. PubMed ID: 31707937
[TBL] [Abstract][Full Text] [Related]
26. What is the meaning of provoked spasm phenotypes by vasoreactivity testing?
Sueda S; Kurokawa K; Sakaue T; Ikeda S
J Cardiol; 2024 Jan; 83(1):1-7. PubMed ID: 37453595
[TBL] [Abstract][Full Text] [Related]
27. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.
Shin DI; Baek SH; Her SH; Han SH; Ahn Y; Park KH; Kim DS; Yang TH; Choi DJ; Suh JW; Kwon HM; Lee BK; Gwon HC; Rha SW; Jo SH
JACC Cardiovasc Interv; 2015 Jun; 8(7):914-23. PubMed ID: 26003026
[TBL] [Abstract][Full Text] [Related]
28. Which Coronary Artery Should Be Preferred for Starting the Coronary Spasm Provocation Test?
Teragawa H; Uchimura Y; Oshita C; Hashimoto Y; Nomura S
Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895453
[TBL] [Abstract][Full Text] [Related]
29. One of six patients with non-ischemic heart disease exhibit provoked coronary spasms: non-ischemic heart disease associated with ischemia?
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Intern Med; 2015; 54(3):281-6. PubMed ID: 25748736
[TBL] [Abstract][Full Text] [Related]
30. Intracoronary ergonovine testing among 505 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease.
Sueda S; Sakaue T
Heart Vessels; 2022 Jun; 37(6):931-941. PubMed ID: 35059807
[TBL] [Abstract][Full Text] [Related]
31. Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis.
Shimokawa H; Tomoike H; Nabeyama S; Yamamoto H; Ishii Y; Tanaka K; Nakamura M
Am Heart J; 1985 Aug; 110(2):300-10. PubMed ID: 4025107
[TBL] [Abstract][Full Text] [Related]
32. Overview of complications during pharmacological spasm provocation tests.
Sueda S; Kohno H
J Cardiol; 2016 Jul; 68(1):1-6. PubMed ID: 27234219
[TBL] [Abstract][Full Text] [Related]
33. Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine.
Sueda S; Kohno H; Fukuda H; Inoue K; Suzuki J; Watanabe K; Ochi T; Uraoka T
Coron Artery Dis; 2002 Jun; 13(4):231-6. PubMed ID: 12193850
[TBL] [Abstract][Full Text] [Related]
34. The acetylcholine administration time plays the key role for provoked spasm in the spasm provocation test.
Sueda S; Kohno H
J Cardiol; 2017 Aug; 70(2):141-146. PubMed ID: 27988074
[TBL] [Abstract][Full Text] [Related]
35. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
[TBL] [Abstract][Full Text] [Related]
36. Sex-related Differences in Patients with Positive Coronary Spasm as Identified by Acetylcholine Testing.
Sueda S; Sakaue T
Intern Med; 2021 Aug; 60(15):2357-2365. PubMed ID: 33583899
[TBL] [Abstract][Full Text] [Related]
37. Assessment of coronary spasms with transluminal attenuation gradient in coronary computed tomography angiography.
Park JY; Kang EJ; Kim MH; Yong HS; Rha SW
PLoS One; 2022; 17(7):e0271189. PubMed ID: 35802711
[TBL] [Abstract][Full Text] [Related]
38. Impact of pharmacological spasm provocation test in patients with a history of syncope.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):126-133. PubMed ID: 28905210
[TBL] [Abstract][Full Text] [Related]
39. Complete definite positive spasm on acetylcholine spasm provocation tests: comparison of clinical positive spasm.
Sueda S; Miyoshi T; Sasaki Y; Ohshima K; Sakaue T; Habara H; Kohno H
Heart Vessels; 2016 Feb; 31(2):143-51. PubMed ID: 25366988
[TBL] [Abstract][Full Text] [Related]
40. Increased circulating malondialdehyde-modified low-density lipoprotein levels in patients with ergonovine-induced coronary artery spasm.
Ito T; Fujita H; Tani T; Sugiura T; Ohte N
Int J Cardiol; 2015 Apr; 184():475-480. PubMed ID: 25756568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
